Stock Screener ETF Screener

Penny Stock Screener Technical Analysis Screener

Dividend Center Best Dividend Stocks

Best High Yield Dividend Stocks Dividend Aristocrats Dividend Stock Comparison

Dividend Calculator Dividend Returns Comparison Dividend Calendar

My Experts Top Analysts Top Financial Bloggers Top-Performing Corporate Insiders Top Hedge Fund Managers Top Research Firms Top Individual Investors

Education

Personal Finance How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire Arrived EquityMultiple

Follow Us

TOOLS

Top Insiders Stocks

Notification Center

Top Smart Score Stocks

Plans & Pricing

Research Tools

Trending Stocks

Most Visited Websites

Daily Feeds

Daily Analyst Ratings

Daily Insider Trading Tracker

Calendars

Earnings Calendar

Dividend Calendar

Economic Calendar

Market Holidays

Economic Indicators

Economic Indicators Center

Unemployment Rate

Federal Funds Rate

Class Actions

Calculators

Dividend Calculator

Dividend Yield Calculator

Options Profit Calculator

Dollar Cost Averaging

Penny Stock Screener

Technical Analysis Screener

Dividend Center

Best Dividend Stocks

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Investing & Retirement

Spending & Savings

Calculators

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Enterprise Solutions

Education

How To Use TipRanks

About Us

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

TipRanks News Wire

Follow Us

Verve Therapeutics (VERV)

NASDAQ:VERV

US Market

VERV

Verve Therapeutics

Analyst Forecasts

Technical Analysis

RESEARCH TOOLS

Top Analyst Stocks

Top Smart Score Stocks

reports

Verve Therapeutics (VERV) Stock News & Sentiment

573 Followers

Promising Outlook for Verve Therapeutics: Buy Rating Backed by Innovative Treatments and Strategic Partnerships

Ratings

Promising Outlook for Verve Therapeutics: Buy Rating Backed by Innovative Treatments and Strategic Partnerships

23h ago

Optimistic Outlook for Verve Therapeutics Amid Promising Developments and Strategic Partnerships

Ratings

Optimistic Outlook for Verve Therapeutics Amid Promising Developments and Strategic Partnerships

1d ago

Buy Rating for Verve Therapeutics: VERVE-102’s Enhanced Safety and Promising Efficacy Boost Investor Confidence

Ratings

Buy Rating for Verve Therapeutics: VERVE-102’s Enhanced Safety and Promising Efficacy Boost Investor Confidence

15d ago

Verve Therapeutics Reports Q3 Progress and Financials

Company Announcements

Verve Therapeutics Reports Q3 Progress and Financials

4M ago

Verve Therapeutics, Inc. (VERV) Q3 Earnings Cheat Sheet

Pre-Earnings

Verve Therapeutics, Inc. (VERV) Q3 Earnings Cheat Sheet

4M ago

Verve Therapeutics’ (VERV) Gene-Editing Therapies Could Be a Game Changer

Market News

Verve Therapeutics’ (VERV) Gene-Editing Therapies Could Be a Game Changer

6M ago

Levi & Korsinsky LLP Notifies Shareholders of Verve Therapeutics, Inc.(VERV) of a Class Action Lawsuit and an Upcoming Deadline

Class Action

Levi & Korsinsky LLP Notifies Shareholders of Verve Therapeutics, Inc.(VERV) of a Class Action Lawsuit and an Upcoming Deadline

6M ago

More VERV News >

VERV News on the Web

2025-01-29

Verve Therapeutics to Participate in the Guggenheim Securities SMID Cap Biotech Conference

Yahoo Finance

Neutral

2025-01-27

Companies Like Verve Therapeutics Are In A Position To Invest In Growth

Yahoo Finance

Neutral

2025-01-23

Verve Therapeutics Moves 18.7% Higher: Will This Strength Last?

Yahoo Finance

Neutral

2025-01-23

Verve Therapeutics (VERV) Moves 18.7% Higher: Will This Strength Last?

Zacks

Neutral

2025-01-09

3 Small-Cap Healthcare Stocks With Big Upside Potential

StockNews

Bullish

2024-12-10

Stifel Nicolaus Sticks to Their Buy Rating for Verve Therapeutics (VERV)

TipRanks News

Bullish

2024-12-10

Verve Therapeutics has positive read from NewAmsterdam data, says Stifel

The Fly

Neutral

2024-11-05

Verve Therapeutics (VERV) Reports Q3 Loss, Tops Revenue Estimates

Zacks

Neutral

News Score - Last 7 Days

Neutral

VERV

Sector Average

Media Buzz

This Week0 articles

Weekly Average0 articles

News Sentiment

This Week50%

Sector Average57%

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is VERV’s Media Buzz Sentiment?

Currently, no data Available

What is VERV’s weekly average amount of articles?

Currently, no data Available

What is VERV’s News Sentiment?

50% of articles about VERV were positive this week, compared to its sector average of 57%.

Healthcare Stocks that are Trending in the News

SHGSingular Health Group Ltd

RCUSArcus Biosciences

HCMHUTCHMED

PENPenumbra

AMNAMN Healthcare Services

Showing the stocks with the most bullish news sentiment over the past week

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing